Review



j558l  (CancerTools Org)


Bioz Verified Symbol CancerTools Org is a verified supplier
Bioz Manufacturer Symbol CancerTools Org manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    CancerTools Org j558l
    J558l, supplied by CancerTools Org, used in various techniques. Bioz Stars score: 99/100, based on 382 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/j558l/J558L/custom%40153661%4042486329
    Average 99 stars, based on 382 article reviews
    j558l - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Clone Assay:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Plasmid Preparation:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Transfection:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Cell Culture:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Control:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Isolation:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Magnetic Beads:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Mouse Assay:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Stable Transfection:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Expressing:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Transformation Assay:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    FACS:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Software:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a

    Derivative Assay:

    Article Title: Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression.
    Article Snippet: ots indicate the percentages of cells in the respective gates. B cells cultured in medium without cytokine supplements served as -ve control, while cells cultured in medium supplemented with CM of the J558L cell line producing IL7 were used as +ve survival control. Statistical analysis of CD19LoCD11b+ cells in both large (FSCHi) (upper panel) and small (FSCLo) (lower panel) cell populations. Data a



    Similar Products

    99
    CancerTools Org j558l
    J558l, supplied by CancerTools Org, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/j558l/J558L/custom%40153661%4042486329
    Average 99 stars, based on 1 article reviews
    j558l - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results